OTCMKTS:EDTXF

Spectral Medical News Headlines

$0.30
-0.01 (-3.07 %)
(As of 08/2/2021 11:53 AM ET)
Add
Compare
Today's Range
$0.27
$0.30
50-Day Range
$0.29
$0.44
52-Week Range
$0.27
$0.60
Volume6,000 shs
Average Volume15,380 shs
Market Capitalization$80.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.37

Spectral Medical (OTCMKTS EDTXF) News Headlines Today

SourceHeadline
Spectral Medical Inc. Closes $10 Million Offering of UnitsSpectral Medical Inc. Closes $10 Million Offering of Units
finance.yahoo.com - July 27 at 9:30 AM
Spectral Medical (OTCMKTS:EDTXF) versus Motus GI (NASDAQ:MOTS) Critical ReviewSpectral Medical (OTCMKTS:EDTXF) versus Motus GI (NASDAQ:MOTS) Critical Review
americanbankingnews.com - July 24 at 11:12 PM
BRIEF-Spectral Medical Announces $10 Million OfferingBRIEF-Spectral Medical Announces $10 Million Offering
msn.com - July 23 at 9:20 AM
Spectral Medical Inc. Announces $10 Million OfferingSpectral Medical Inc. Announces $10 Million Offering
finance.yahoo.com - July 21 at 1:59 PM
Spectral Announces Fourth Quarter and Fiscal 2020 Results and Corporate UpdateSpectral Announces Fourth Quarter and Fiscal 2020 Results and Corporate Update
finance.yahoo.com - March 26 at 8:37 AM
Spectral Medical Engages Crescendo Communications to Provide Investor Relations Services in the United StatesSpectral Medical Engages Crescendo Communications to Provide Investor Relations Services in the United States
finance.yahoo.com - March 4 at 8:08 AM
Spectral Medical to participate at the upcoming H.C. Wainwright Global Life Sciences ConferenceSpectral Medical to participate at the upcoming H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 9:15 AM
Spectral Medical Inc. (TSE:EDT) Is Expected To Breakeven In The Near FutureSpectral Medical Inc. (TSE:EDT) Is Expected To Breakeven In The Near Future
finance.yahoo.com - March 1 at 12:15 PM
Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical has been Granted FDA IDE Authorization to Conduct a Trial of DIMI for Home Hemodialysis UseSpectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical has been Granted FDA IDE Authorization to Conduct a Trial of DIMI for Home Hemodialysis Use
finance.yahoo.com - February 23 at 8:09 AM
Spectral Medical to Present at the SNN Network Canada Virtual Event on January 7, 2021Spectral Medical to Present at the SNN Network Canada Virtual Event on January 7, 2021
finance.yahoo.com - January 6 at 8:24 AM
How Much Is Spectral Medicals (TSE:EDT) CEO Getting Paid?How Much Is Spectral Medical's (TSE:EDT) CEO Getting Paid?
finance.yahoo.com - December 31 at 11:13 AM
Spectral Medical to Host Virtual Investor Day on December 4, 2020Spectral Medical to Host Virtual Investor Day on December 4, 2020
finance.yahoo.com - November 27 at 9:18 AM
Spectral Medical Announces that its wholly owned subsidiary Dialco Medical has received MDSAP certificationSpectral Medical Announces that its wholly owned subsidiary Dialco Medical has received MDSAP certification
finance.yahoo.com - November 24 at 8:53 AM
Spectral Medical Announces Report on Clinical Implementation of SAMI Amid COVID-19 Published in the Journal of Blood PurificationSpectral Medical Announces Report on Clinical Implementation of SAMI Amid COVID-19 Published in the Journal of Blood Purification
finance.yahoo.com - November 11 at 12:40 PM
Spectral and Dialco Sponsored Symposiums at the 38th Vicenza Course on AKI and CRRTSpectral and Dialco Sponsored Symposiums at the 38th Vicenza Course on AKI and CRRT
finance.yahoo.com - November 3 at 8:02 AM
Spectral to Present at H.C. Wainwright & Co. 22nd Annual Global Investment ConferenceSpectral to Present at H.C. Wainwright & Co. 22nd Annual Global Investment Conference
finance.yahoo.com - September 8 at 8:34 AM
U.S. FDA Grants 510(k) Clearance for Spectral’s DIMIU.S. FDA Grants 510(k) Clearance for Spectral’s DIMI
finance.yahoo.com - August 31 at 10:05 AM
US FDA Approves Spectral Medical’s Protocol Amendment for TIGRISUS FDA Approves Spectral Medical’s Protocol Amendment for TIGRIS
finance.yahoo.com - August 10 at 10:13 AM
Spectral Medical Inc. Appoints John E. Nosenzo to its Board of DirectorsSpectral Medical Inc. Appoints John E. Nosenzo to its Board of Directors
finance.yahoo.com - August 4 at 8:22 AM
Spectral Medical Inc. Announces Proposed Public Offering of UnitsSpectral Medical Inc. Announces Proposed Public Offering of Units
www.benzinga.com - May 27 at 5:41 PM
Health Canada Issues an Interim Order for Spectral Medicals PMX to Treat COVID-19 PatientsHealth Canada Issues an Interim Order for Spectral Medical's PMX to Treat COVID-19 Patients
www.benzinga.com - April 20 at 8:41 AM
US FDA Approves an Investigational Device Exemption for Spectral Medical PMX to Treat COVID-19 Patients Suffering from Septic ShockUS FDA Approves an Investigational Device Exemption for Spectral Medical PMX to Treat COVID-19 Patients Suffering from Septic Shock
www.benzinga.com - April 14 at 12:33 PM
SPECTRAL MEDICAL INC. WITHDRAWS PUBLIC OFFERINGSPECTRAL MEDICAL INC. WITHDRAWS PUBLIC OFFERING
finance.yahoo.com - March 12 at 5:09 PM
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and CanadaBaxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
www.globenewswire.com - February 4 at 7:30 AM
Baxter in-licenses rights to endotoxin filterBaxter in-licenses rights to endotoxin filter
seekingalpha.com - February 4 at 7:30 AM
This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.